Prof. Gus Gazzard was made a Consultant in the Glaucoma Service at Moorfields Eye Hospital in 2009 after a Clinical Fellowship at Moorfields 2006-08 and a Research Fellowship with Prof Peng Khaw in Singapore 1999-2002, where he ran and established several clinical trials (including the Singapore-5FU and the ACLIPS trials, both published in Ophthalmology).
In 2012 he established, as Chief Investigator, the 6 year NIHR-HTA funded (£1.7m) multi-centre LiGHT trial of selective laser trabeculoplasty which completed recruitment in October 2014 on target and on-time.
Gus’ research interests as, University College London Professor of Ophthalmology (Glaucoma Studies), include angle closure glaucoma, selective laser trabeculoplasty, randomised controlled trials of glaucoma treatments, anterior segment imaging and the epidemiology of myopia. He is a member of the EAGLE Study Group (an international multi-centre RCT of early lens extraction in angle-closure), on the advisory board for the ZAP trial (an RCT assessing prophylactic laser iridotomy), co-founded the European Glaucoma Society Special Interest Group in Angle Closure and was Clinical Director for Moorfields South, including St George’s teaching hospital, until 2013 when he took up an academic position at UCL.